CompletedNCT05177146
Ketamine research on suicide risk in bipolarity depression
About this title
Neural Correlates of Ketamine's Anti-suicidal Effects in Bipolar Depression
Read the official source — NCT05177146Medication studyAges 24–65Canada
Understand this study
Who was this study for?
Listed age limits: 24 years to 65 years.
- Listed locations
- TorontoSee all locations and recruitment
Study information
Study start dateStarted: May 4, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 16
- Sponsor
- Centre for Addiction and Mental Health
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Locations
- Canada
- Age range
- From 24 Years to 65 Years
- Official registry ID
- NCT05177146
- Official title
Show the full official title
Neural Correlates of Anti-suiciDal rEsponse to kEtamine in Treatment Resistant biPolar dePression (DEEPP-Study)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Toronto
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre for Addiction and Mental Health, a hospital or academic medical center.
Did this study involve medication?
Yes. The study involved medication, including Intravenous Ketamine (IV).
Who was this study for?
Listed age limits: 24 years to 65 years.
